Profil bibliographique

Gissella Mernies

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

7Publications signalées

16Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentHIV-related health complications and treatmentsHIV Research and TreatmentSARS-CoV-2 and COVID-19 Research

Publications récentes

Accès ouvert 2026 articleOpenAlex

The Caribbean, Central and South America Network for HIV Epidemiology: 20 Years of HIV Research in the Region

Jessica L. Castilho, Stephany N. Duda, Bryan E. Shepherd, Timothy R. Sterling et autres

1 citationJournal of the International AIDS Society

Accès ouvert 2026 articleOpenAlex

Persistence on Oral HIV Pre‐Exposure Prophylaxis Among Key Populations at a Centre in Buenos Aires: A Survival Analysis of a Real‐World Cohort

Julián García, D. Salusso, Gissella Mernies, María M. Sandoval et autres

1 citationJournal of the International AIDS Society

2025 articleOpenAlex

Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study

María Inés Figueroa, Carlos Brites, Diego Cecchini, Aline de Oliveira Ramalho et autres

11 citationsClinical Infectious Diseases

Accès ouvert 2025 articleOpenAlex

Immune response induced by the recombinant novel coronavirus vaccine (Adenovirus type 5 vector) (Ad5-nCoV) in persons living with HIV (PLWH)

Pedro Cahn, Luis Barreto, María Inés Figueroa, Valeria Fink et autres

0 citationsPLoS ONE

Accès ouvert 2025 preprintOpenAlex

Efficacy and Safety of Dual Therapy with Dolutegravir/Lamivudine in Treatment-Naive Persons with CD4 Counts <200/mm3: 48 Weeks Results of the DOLCE Study

María Inés Figueroa, Carlos Brites, Diego Cecchini, Aline de Oliveira Ramalho et autres

1 citationSSRN Electronic Journal

2024 articleOpenAlex

Dual therapy based on co-formulated darunavir/ritonavir plus lamivudine for initial therapy of HIV infection: The ANDES randomized controlled trial

María Inés Figueroa, Omar Sued, Diego Cecchini, María Dolores Calvo Sánchez et autres

2 citationsInternational Journal of Antimicrobial Agents

Accès ouvert 2024 conference-abstractOpenAlex

Comparable efficacy and safety of dolutegravir/lamivudine to a three-drug regimen among ARV naive people living with HIV with CD4 <200/mm3 : the DOLCE study

María Inés Figueroa, Carlos Brites, Diego Cecchini, Aline Santos Ramalho Teixeira Benevenuto et autres

0 citationsLume (Universidade Federal do Rio Grande do Sul)

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.